Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Hypotensive effects of hawthorn for patients with diabetes taking prescription drugs: a randomised controlled trial.

Walker AF, Marakis G, Simpson E, Hope JL, Robinson PA, Hassanein M, Simpson HC.

Br J Gen Pract. 2006 Jun;56(527):437-43.

2.

Promising hypotensive effect of hawthorn extract: a randomized double-blind pilot study of mild, essential hypertension.

Walker AF, Marakis G, Morris AP, Robinson PA.

Phytother Res. 2002 Feb;16(1):48-54.

PMID:
11807965
3.

Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.

Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.

Nutr Metab Cardiovasc Dis. 2006 Mar;16(2):137-47. Epub 2005 Oct 20.

PMID:
16487914
4.

Pharmacological interventions for hypertension in children.

Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R.

Evid Based Child Health. 2014 Sep;9(3):498-580. doi: 10.1002/ebch.1974. Review.

PMID:
25236305
5.

Hawthorn extract for treating chronic heart failure.

Pittler MH, Guo R, Ernst E.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD005312. doi: 10.1002/14651858.CD005312.pub2. Review.

PMID:
18254076
6.

Empagliflozin reduces blood pressure in patients with type 2 diabetes and hypertension.

Tikkanen I, Narko K, Zeller C, Green A, Salsali A, Broedl UC, Woerle HJ; EMPA-REG BP Investigators.

Diabetes Care. 2015 Mar;38(3):420-8. doi: 10.2337/dc14-1096. Epub 2014 Sep 30.

PMID:
25271206
7.
8.

Pharmacological interventions for hypertension in children.

Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R.

Cochrane Database Syst Rev. 2014 Feb 1;(2):CD008117. doi: 10.1002/14651858.CD008117.pub2. Review.

PMID:
24488616
9.

A cluster randomised controlled trial of the effect of a treatment algorithm for hypertension in patients with type 2 diabetes.

Bebb C, Kendrick D, Coupland C, Madeley R, Stewart J, Brown K, Burden R, Sturrock N.

Br J Gen Pract. 2007 Feb;57(535):136-43.

10.

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, Camel G, Davis BR, Frost PH, Gonzalez N, Guthrie G, Oberman A, Rutan GH, Stamler J.

JAMA. 1996 Dec 18;276(23):1886-92. Erratum in: JAMA 1997 May 7;277(17):1356.

PMID:
8968014
11.
13.
14.

Aliskiren as add-on therapy in the treatment of hypertensive diabetic patients inadequately controlled with valsartan/HCT combination: a placebo-controlled study.

Drummond W, Sirenko YM, Ramos E, Baek I, Keefe DL.

Am J Cardiovasc Drugs. 2011 Oct 1;11(5):327-33. doi: 10.2165/11591970-000000000-00000.

PMID:
21846154
15.

Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes Mellitus.

Kovacs CS, Seshiah V, Merker L, Christiansen AV, Roux F, Salsali A, Kim G, Stella P, Woerle HJ, Broedl UC; EMPA-REG EXTEND™ PIO investigators.

Clin Ther. 2015 Aug;37(8):1773-88.e1. doi: 10.1016/j.clinthera.2015.05.511. Epub 2015 Jun 29.

PMID:
26138864
16.

Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.

Musini VM, Nazer M, Bassett K, Wright JM.

Cochrane Database Syst Rev. 2014 May 29;(5):CD003824. doi: 10.1002/14651858.CD003824.pub2. Review.

PMID:
24869750
17.

Cochrane in context: pharmacological interventions for hypertension in children.

Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh RS.

Evid Based Child Health. 2014 Sep;9(3):581-3. doi: 10.1002/ebch.1975. Review.

PMID:
25236306
18.

Effects of nitrendipine and enalapril on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension.

Gerritsen TA, Bak AA, Stolk RP, Jonker JJ, Grobbee DE.

J Hypertens. 1998 May;16(5):689-96.

PMID:
9797181
19.

Effect of hawthorn standardized extract on flow mediated dilation in prehypertensive and mildly hypertensive adults: a randomized, controlled cross-over trial.

Asher GN, Viera AJ, Weaver MA, Dominik R, Caughey M, Hinderliter AL.

BMC Complement Altern Med. 2012 Mar 29;12:26. doi: 10.1186/1472-6882-12-26.

20.

Prevention of microalbuminuria in patients with type 2 diabetes and hypertension.

Menne J, Izzo JL Jr, Ito S, Januszewicz A, Katayama S, Chatzykirkou C, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G, Haller H; ROADMAP investigators.

J Hypertens. 2012 Apr;30(4):811-8; discussion 818. doi: 10.1097/HJH.0b013e328351856d. Erratum in: J Hypertens. 2012 Aug;30(8):1679.

PMID:
22418908

Supplemental Content

Support Center